Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INDV-2000 Phase 1 SAD and Food Effect Study
NCT04413552Phase 1Completed
- Sponsor
- Indivior
- Start
- Jul 2020
- Primary completion
- Apr 2021
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of C4X3256 in opioid use disorder (OUD) (3 arms), sponsored by Indivior. Primary endpoint: Number of Participants With Treatment-emergent Adverse Events. Started Jul 2020; status: completed.
02
Drugs
C4X3256
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04413552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04413552.